{"nct_id":"NCT01379534","title":"A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer","status":"COMPLETED","status_verified_date":"2015-05","start_date":"2011-11","start_date_type":null,"primary_completion_date":"2014-03","primary_completion_date_type":"ACTUAL","completion_date":"2014-03","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}